Is your child experiencing irritability due to autism spectrum disorder?

It is estimated that 1 in 59 children in the United States has autism spectrum disorder (ASD). Irritability associated with ASD is often caused by multiple underlying comorbid conditions, many of which are linked to serotonergic system dysfunction. The investigational drug is designed to specifically block serotonergic neurotransmission to help alleviate irritability symptoms.

Study Benefits:

• Compensation for time and travel
• Optional yearlong open-label extension study after completion of this study (if qualified)
• The investigational drug has been FDA approved for the treatment of adults with Parkinson’s with psychosis.

Study Participant Criteria:

• Male or females
• 5 to 17 years of age
• Autism with irritability that disrupts family life, education, or social life

Study Participant Expectations

• 6-week treatment period with weekly clinic visits
• Daily oral medication
• 4 blood draws throughout the study

“Did You Know”

• It is estimated that 1 in 59 children in the United States has autism spectrum disorder (ASD).